Diagnosis and Treatment of Cranial N euralgias
References (25)
Trigeminal neuralgia and related disorders
Neurol Clin
(1989)- et al.
Percutaneous procedures for trigeminal neuralgia: Microcompression versus radiofrequency thermocoagulation
Pain
(1989) - et al.
Glossopharyngeal and vagal neuralgia
Br Med J
(1967) Medical treatment of trigeminal neuralgia
Clin Neurosurg
(1977)Trigeminal neuralgia: A practical approach to treatment
Drugs
(1982)- et al.
Five-and-a-halfs years experience with percutaneous retrogasserian glycerol rhizotomy in treatment of trigeminal neuralgia
Appl Neurophysiol
(1987) Atypical facial neuralgia, a syndrome of vascular pain
Ann Otol
(1932)Pharmacological consideration of anticonvulsants
Headache
(1969)The pharmacology of trigeminal neuralgia
Clin Neuropharmacol
(1989)- et al.
Baclofen in the treatment of refractory trigeminal neuralgia
Neurology
(1979)
Trigeminal neuralgia. Concepts regarding etiology and pathogenesis
Arch Neurol
Trigeminal neuralgia treated by injection of glycerol into the trigeminal cistern
Neurosurgery
Cited by (22)
Pregabalin treatment in a pregnant woman with glossopharyngeal neuralgia
2020, Brazilian Journal of OtorhinolaryngologyGlossopharyngeal Neuralgia Treatment Outcomes After Nerve Section, Microvascular Decompression, or Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis
2018, World NeurosurgeryCitation Excerpt :Often described as “sharp,” “stabbing,” or “shock-like,” GPN is typically triggered by manual stimulation, such as swallowing, chewing, talking, coughing, or yawning. Just as with trigeminal neuralgia, first-line therapy for GPN is pharmacologic, predominantly using neuromodulating agents, including carbamazepine, gabapentin, and pregabalin.5-7 For severe or medication-refractory GPN, interventional treatment can be considered, including direct nerve section (NS), microvascular decompression (MVD), or stereotactic radiosurgery (SRS).
Glossopharyngeal neuralgia treated with gamma knife radiosurgery
2010, World NeurosurgeryHeadaches in Children and Adolescents
2007, Current Problems in Pediatric and Adolescent Health CareCitation Excerpt :TGN occurs in about 1 in 25,000 in the general population and is uncommon before the third decade, with only 1% of the cases occurring before 20 years of age. The medical management of choice is carbamazepine but surgical decompression may be necessary in selected instances.139 A high proportion of TGN in childhood is associated with defined organic pathology.140-144
The "other" primary headaches in children and adolescents
2005, Pediatric NeurologyHeadaches in the elderly
1993, Journal of Pain and Symptom Management